We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
(-3.3%)
Cap. Flow
+$2.69B
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$620M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$242M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$232M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$168M |
| 5 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$255M |
| 2 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$106M |
| 3 |
iShares Expanded Tech Sector ETF
IGM
|
+$83.9M |
| 4 |
Roper Technologies
ROP
|
+$78.2M |
| 5 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.07% |
| 2 | Healthcare | 8.95% |
| 3 | Financials | 8.81% |
| 4 | Industrials | 6.54% |
| 5 | Consumer Discretionary | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Elanco Animal Health
ELAN
$11.5B
| $859K | ﹤0.01% |
69,235
-148,627
| -68% | -$2.6M |
|
|
SDHY
2502
PGIM Short Duration High Yield Opportunities Fund
SDHY
$400M
| $859K | ﹤0.01% |
59,745
-53,857
| -47% | -$823K |
|
2503
Invesco Trust Investment Grade Municipals
VGM
$569M
| $859K | ﹤0.01% |
91,774
+569
| +0.6% | +$5.95K |
|
2504
Community Bank
CBU
$3.47B
| $856K | ﹤0.01% |
14,244
+74
| +0.5% | +$4.87K |
|
2505
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$569M
| $856K | ﹤0.01% |
34,748
-14,443
| -29% | -$366K |
|
2506
Ranger Energy Services
RNGR
$412M
| $856K | ﹤0.01% |
87,548
+70,832
| +424% | +$668K |
|
2507
iShares MSCI China ETF
MCHI
$6.16B
| $854K | ﹤0.01% |
20,057
+361
| +2% | +$17.8K |
|
2508
Nuveen Multi-Asset Income Fund
NMAI
$495M
| $853K | ﹤0.01% |
74,880
+29,550
| +65% | +$395K |
|
2509
Invesco DB Energy Fund
DBE
$90.5M
| $851K | ﹤0.01% |
37,584
-169,837
| -82% | -$4.2M |
|
2510
Corcept Therapeutics
CORT
$12.2B
| $850K | ﹤0.01% |
33,149
+951
| +3% | +$25.4K |
|
2511
Nuveen Global High Income Fund
JGH
$354M
| $849K | ﹤0.01% |
80,511
-10,084
| -11% | -$120K |
|
2512
The GEO Group
GEO
$4.01B
| $845K | ﹤0.01% |
109,701
+67,473
| +160% | +$498K |
|
2513
Intrepid Potash
IPI
$493M
| $844K | ﹤0.01% |
21,341
+2,419
| +13% | +$105K |
|
2514
Liberty Latin America Class A
LILA
$1.67B
| $842K | ﹤0.01% |
200,155
-5,402
| -3% | -$26.1K |
|
2515
SkinHealth Systems
SKIN
$86.2M
| $841K | ﹤0.01% |
71,373
-9,846
| -12% | -$124K |
|
|
TBCH
2516
Turtle Beach Corp
TBCH
$230M
| $841K | ﹤0.01% |
123,290
-64,503
| -34% | -$676K |
|
2517
Invesco NASDAQ Internet ETF
PNQI
$545M
| $839K | ﹤0.01% |
36,885
-1,125
| -3% | -$29K |
|
2518
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$540M
| $836K | ﹤0.01% |
9,421
+961
| +11% | +$87.1K |
|
|
VISN
2519
Vistance Networks Inc
VISN
$2.63B
| $833K | ﹤0.01% |
90,450
-12,330
| -12% | -$118K |
|
2520
Unitil
UTL
$992M
| $832K | ﹤0.01% |
17,903
-645
| -3% | -$34.9K |
|
2521
Amplify Lithium & Battery Technology ETF
BATT
$124M
| $831K | ﹤0.01% |
64,964
-810
| -1% | -$11.9K |
|
|
PBFX
2522
DELISTED
PBF LOGISTICS LP
PBFX
| $829K | ﹤0.01% |
43,889
+22,882
| +109% | +$406K |
|
2523
Digital Turbine
APPS
$1.51B
| $826K | ﹤0.01% |
57,289
-2,516
| -4% | -$48.1K |
|
|
DSL
2524
DoubleLine Income Solutions Fund
DSL
$1.24B
| $815K | ﹤0.01% |
75,456
-19,423
| -20% | -$238K |
|
|
SILK
2525
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $815K | ﹤0.01% |
18,105
+1,254
| +7% | +$53.9K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
- Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
- Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
- Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
- Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
- Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
- Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.
Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.